| • Science | • People | • Locations | • Timeline |
As the name implies, the hemoglobin appears in urine in attacks (paroxysms). The symptom in itself is harmless, although excessive hemolysis could cause renal failure.
More importantly, PNH can cause aplastic anemia and thrombosis. Aplastic anemia may warrant blood transfusion (transfused blood is not hemolysed), and thrombosis can occur in the vein tree and less commonly in arteries. A very characteristic form of venous thrombosis is Budd-Chiari syndrome, thrombosis of the hepatic vein , and cerebral venous thrombosis.
Many patients with aplastic anemia develop PNH (10-33%), possibly signifying an escape mechanism.
Traditionally, this was done with Ham's test. Modern methods include flow cytometry for CD55, CD16 and CD59 on white and red blood cells. Dependent on the presence of these molecules on the cell surface, they are classified as Type I, II or III PNH cells.
Treatment is symptomatic ( blood transfusion). Recent research has suggested that prophylactic use of anticoagulants ( warfarinWarfarin (also known under the brand name Coumadin ) is an anticoagulant medication that can be given orally. Normally, vitamin K is converted to vitamin K epoxide in the liver. This epoxide is then reduced by the enzyme epoxide reductase. The reduced for) might be warranted.
A new agent, eculizumab, might protect blood cells against immune destruction by inhibiting the complement systemThe complement system is a complex biochemical cascade of the immune system, leading to cytolysis, chemotaxis, opsonization and inflammation, it can mark pathogens for phagocytosis. It consists of more than 35 proteins. 12 which are directly involved in t.
In severe aplasia, bone marrow transplantBone marrow transplantation is a medical procedure that involves stem cell transplantation. The common feature of recipients is a need for blood stem cells. Most recipients are leukemia patients or others who have been exposed to high doses of chemotheraps are occasionally undertaken.
PNH is caused by a mutation in the GPI anchorA GPI anchor (phosphatidyl-inositol glycane) is a common modification of the C terminus of membrane attached proteins in which a phosphatidyl inositol moiety is linked through glucosamine and mannose to a phosphoryl ethanolamine residue that is linked to. This molecule links many proteins to the cell membrane, but in blood cells the main GPI-linked molecules are CD16, CD55 and CD59 (CD is an acronym of cluster of differentiation). These molecules protect blood cells from destruction by the complement system.
Hematology